Speech-Language Pathologists in Peru, IL Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Julee Nawa Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Walnut St, Peru, IL 61354 Phone: 815-780-3509

Kristina Selquist, M.S., CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2501 1st St, Peru, IL 61354 Phone: 181-522-0780    Fax: 181-522-0758

Angie Lamps, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 Church St, Peru, IL 61354 Phone: 815-223-7723

Mrs. Christine Marie Garretson, MS CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Walnut St, Peru, IL 61354 Phone: 815-780-3309    Fax: 815-224-6744

Mrs. Kelly Schaefer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 33rd St, Peru, IL 61354 Phone: 309-235-1514

Mrs. Andrea V Politsch, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4401 Progress Blvd, Peru, IL 61354 Phone: 815-220-6751

Kami Lynn Becker Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 633 30th St, Peru, IL 61354 Phone: 815-250-0315

Jennifer Calhoun, MA, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1503 Sunset Dr, Peru, IL 61354 Phone: 815-326-3137

News Archive

Takeda resubmits alogliptin and fixed-dose combination therapy NDAs with FDA

Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited announced that its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. has resubmitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for alogliptin and fixed-dose combination therapy alogliptin and pioglitazone for the treatment of type 2 diabetes in adults.

Pioneering technique that uses thermal imaging can help fight obesity

Scientists at The University of Nottingham believe they've found a way of fighting obesity — with a pioneering technique which uses thermal imaging. This heat-seeking technology is being used to trace our reserves of brown fat — the body's 'good fat' — which plays a key role in how quickly our body can burn calories as energy.

Daiichi Sankyo's Benicar receives FDA approval for hypertension treatment in children and adolescents aged 6-16

Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar® (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age. Benicar was originally approved in 2002 for the treatment of hypertension in adults.

Self-propelled microrockets using stomach acid as fuel may help perform microsurgery

An advance in micromotor technology akin to the invention of cars that fuel themselves from the pavement or air, rather than gasoline or batteries, is opening the door to broad new medical and industrial uses for these tiny devices, scientists said here today. Their update on development of the motors - so small that thousands would fit inside this "o" - was part of the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society, being held here this week.

Cancer cells release biological 'drones' to assist in the fight against immune system

Cancer cells are more than a lump of cells growing out of control; they participate in active combat with the immune system for their own survival. Being able to evade the immune system is a hallmark of cancer.

Read more Medical News

› Verified 7 days ago